Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Oxytocin on Approach-Avoidance Tendencies
NCT04443647Completed
- Sponsor
- KU Leuven
- Start
- Dec 2018
- Primary completion
- Jan 2020
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin nasal spray (2 arms), sponsored by KU Leuven. Primary endpoints: Change in EEG frontal alpha asymmetry, Change in behavioral approach-avoidance and 1 more. Started Dec 2018; status: completed.
02
Drugs
oxytocin nasal spray
Beyond the preview
Go deeper on NCT04443647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04443647.